189 related articles for article (PubMed ID: 15554889)
1. Neonatal screening for congenital adrenal hyperplasia.
van der Kamp HJ; Wit JM
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U71-5. PubMed ID: 15554889
[TBL] [Abstract][Full Text] [Related]
2. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
4. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
[TBL] [Abstract][Full Text] [Related]
5. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
Cavarzere P; Camilot M; Teofoli F; Tatò L
Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
[TBL] [Abstract][Full Text] [Related]
7. Neonatal screening for congenital adrenal hyperplasia.
Barra CB; Silva IN; Pezzuti IL; Januário JN
Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
[TBL] [Abstract][Full Text] [Related]
9. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
[TBL] [Abstract][Full Text] [Related]
10. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
[TBL] [Abstract][Full Text] [Related]
11. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
12. Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.
Terai I; Yamano K; Ichihara N; Arai J; Kobayashi K
Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F179-83. PubMed ID: 10525019
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
14. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
15. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
Hayashi G; Faure C; Brondi MF; Vallejos C; Soares D; Oliveira E; Brito VN; Mendonca BB; Bachega TA
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):632-7. PubMed ID: 22218447
[TBL] [Abstract][Full Text] [Related]
16. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina.
Gruñieiro-Papendieck L; Chiesa A; Mendez V; Prieto L
J Pediatr Endocrinol Metab; 2008 Jan; 21(1):73-8. PubMed ID: 18404975
[TBL] [Abstract][Full Text] [Related]
17. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
[TBL] [Abstract][Full Text] [Related]
18. Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.
Nascimento ML; Cristiano AN; Campos Td; Ohira M; Cechinel E; Simoni G; Lee Jv; Linhares RM; Silva PC
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):765-71. PubMed ID: 25372587
[TBL] [Abstract][Full Text] [Related]
19. Measurement of Serum 17α-Hydroxyprogesterone in Infants by Radioimmunoassay.
Muñoz LN; Ochetti M; Perez G; Sobrero GM; Silvano LK; Martin SE; Testa GM; Miras MB
Pediatr Endocrinol Rev; 2015 Jun; 12(4):366-72. PubMed ID: 26182481
[TBL] [Abstract][Full Text] [Related]
20. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience].
Cardoso CB; Fonseca AA; Oliveira Mde F; Pereira BB; Guimarães MM
Arq Bras Endocrinol Metabol; 2005 Feb; 49(1):112-9. PubMed ID: 16544042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
